Divis Laboratories was established in 1990 with its fundamentals in research and development. It is mainly focused on developing APIs (Active Pharma Ingredients) and Intermediates.
With an experience of five years, Divis Labs established its first manufacturing facility in 1995 after helping many companies with its consulting strengths. The company has two manufacturing facilities today or units.
One is at Hyderabad where the plant has 13 multi-purpose production blocks with scope of further expansion. The other one is at Vishakhapatnam with 14 production blocks. Both the facilities are primarily aimed at manufacturing APIs and advanced intermediates for discovery compounds, building blocks for peptides and nucleotides as well as carotenoids and chiral ligands. Each of the plants have their R&D center that mainly develops alternative synthesis routes to achieve non-infringement of patents and optimize products without sacrificing quality.
Divis Laboratories is truly a global company in its outlook and strive to attain best standards in quality. Some of the Divis labs products under validation are Vildagliptin, Ranolazine, Linagliptin etc.
The company also exports its products to American and European countries and has two subsidiaries- Divis Laboratories (USA) and Divis Laboratories Europe AG.
The company has its R&D as its strengths and invested approximately 40 crores to fuel its research. The two other strengths are its technologies by which it handles all the hazardous chemicals effectively and Quality units which is further divided into Quality Assurance (QA) and Quality Control (QC) units. Divis Labs has won many awards for its best practices and safety management systems in its endeavor to achieve something great.